Identifying Barriers to Allo Stem Cell Transplants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 1,365 patients (estimated)
- Sponsors
- Memorial Sloan Kettering Cancer Center
- Tags
- Pre-Allogeneic Stem Cell Transplant
- Trial Type
- Observational
- Last Update
- 4 weeks ago
- SparkCures ID
- 1261
- NCT Identifier
- NCT02677064
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.